q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

April 2015 Summary of the Most Recent Updates for the Medicare Part D Plan Formularies (Drug Lists) Part 2

Category: Monthly Formulary Changes
Published: May, 05 2015 08:05:12
< Previous
Next >
The most recent (April 2015) Medicare Part D plan formulary data (or drug lists) updates include the addition of 360 new National Drug Codes (NDC) to the Medicare Part D program.  These represent 216 different drugs, many with multiple strengths or delivery forms. The summary below is reflective of all 360 NDCs, However, since there are so many new NDCs we need to break the NDC details chart into two parts.  Go to the Part 1 blog for the details of the drug in the first 180 new NDCs. This blog details the remaining 180 NDCs.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:


Reason for NDC Addition Occurrences
New Delivery Form 10
New Delivery Form and Strength 16
New Drug 76
New Drug and Delivery Form 6
New Drug and Strength 121
New Drug, Manufacturer, Delivery Form and Strength 5
New Drug, Strength and Delivery Form 3
New Manufacturer 6
New Manufacturer and Delivery Form 6
New Manufacturer and Delivery Form and Strength 21
New Manufacturer and Strength 32
New Package 1
New Strength 57
Total New NDCs 360

The following 180 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area. Go to the Part 1 blog for links to the drug in the first 180 new NDCs.


NDC Drug Name Notes
16781039160 LOCOID 0.1% SOLUTION new drug and delivery form
16781038215 LOCOID 0.1% CREAM new drug and delivery form
30698045901 LOPRESSOR 100 MG TABLET new strength
68308022401 Lorcet 5-325 mg tablet new drug and strength
68308022601 Lorcet hd 10-325 mg tablet new drug and strength
68308022501 Lorcet plus 7.5-325 mg tablet new drug and strength
00310065758 LYNPARZA 50 MG CAPSULE new drug
52427028701 Macrodantin Nitrofurantion crystals 50mg/1 100 CAPSULE in 1 BOTTLE, PLASTIC new strength
63323006409 Magnesium sulfate 50% vial new manufacturer and strength
65580059401 Metadate er 20 mg tablet new manufacturer and strength
62559011016 METOCLOPRAMIDE 5 MG/5 ML SOLN new strength
52544027621 MICROGESTIN 21 1-20 TABLET new drug and strength
52544029021 MICROGESTIN 21 1.5-30 TAB new drug and strength
52544024928 MICROGESTIN FE 1-20 TABLET new drug and strength
52544023328 MICROGESTIN FE 1.5-30 TAB new drug and strength
60809016612 Migergot suppository new drug
23594050501 Millipred 5 mg tablet new delivery form and strength
68968662508 MINIVELLE 0.025 MG PATCH new strength
16781040360 MINOCIN 100 MG PELLETIZED CAP new drug and strength
16781040060 MINOCIN 50 MG PELLETIZED CAP new drug and strength
16781045760 MINOCIN 75 MG PELLETIZED CAP new drug and strength
00004040309 MIRCERA 100 MCG/0.3 ML SYRINGE new drug and strength
00004040109 MIRCERA 50 MCG/0.3 ML SYRINGE new drug and strength
00004040209 MIRCERA 75 MCG/0.3 ML SYRINGE new drug and strength
00409189311 MORPHINE 10 MG/ML ISECURE SYR new strength
00409189211 MORPHINE 8 MG/ML ISECURE SYR new strength
67877023022 MYCOPHENOLATE 200 MG/ML SUSP new manufacturer and strength
00456321060 NAMENDA 10MG TABLET new delivery form and strength
00456341433 NAMENDA XR 14 MG CAPSULE new strength
00456320560 NAMENDA 5MG TABLET new delivery form and strength
00456320014 NAMENDA 5-10MG TITRATION PK new strength
43538094060 NEO-SYNALAR 0.5%-0.025% CREAM new drug
43538017645 Neuac gel new drug
68180088611 Nikki 3 mg-0.02 mg tablet new drug
55111031060 Nizatidine 150mg/1 60 CAPSULE in 1 BOTTLE new manufacturer and strength
00378730153 Norethin-Estrad-Ferr 1-0.02 mg new drug
51660012786 Norlyroc 0.35 mg tablet new drug
67386082019 NORTHERA 100 MG CAPSULE new drug and strength
67386082119 NORTHERA 200 MG CAPSULE new drug and strength
67386082219 NORTHERA 300 MG CAPSULE new drug and strength
00264446010 NUTRILIPID 20 % EMULSION new drug
63459022030 NUVIGIL 200 MG TABLET new strength
00597014360 OFEV 100 MG CAPSULE new drug and strength
00597014560 OFEV 150 MG CAPSULE new drug and strength
60505084505 OLOPATADINE 665 MCG NASAL SPRY new drug
00187305050 ONEXTON GEL PUMP new drug
00310610090 ONGLYZA 2.5 MG TABLET new drug and strength
00310610590 ONGLYZA 5 MG TABLET new drug and strength
63481081460 OPANA ER 10 MG TABLET new strength
63481081660 OPANA ER 20 MG TABLET new strength
63481081760 OPANA ER 30 MG TABLET new strength
63481081860 OPANA ER 40 MG TABLET new strength
63481081260 OPANA ER 5 MG TABLET new strength
00003377211 OPDIVO 40 MG/4 ML VIAL new drug
59212070048 ORAPRED ODT 10 MG TABLET new drug and strength
59212070148 ORAPRED ODT 15 MG TABLET new drug and strength
59212070248 ORAPRED ODT 30 MG TABLET new drug and strength
00781570301 OXYCODONE HCL ER 10 MG TABLET new manufacturer and strength
00781572601 OXYCODONE HCL ER 20 MG TABLET new manufacturer and strength
00781576701 OXYCODONE HCL ER 40 MG TABLET new manufacturer and strength
00781578501 OXYCODONE HCL ER 80 MG TABLET new manufacturer and strength
00228402911 OXYCODONE-IBUPROFEN 5-400 TAB new drug
00409100701 PARICALCITOL 2 MCG/ML VIAL [Zemplar] new manufacturer and delivery form
00409100801 PARICALCITOL 5 MCG/ML VIAL [Zemplar] new manufacturer, strength and delivery form
75987004005 PENNSAID 2% PUMP new manufacturer, strength and delivery form
42998097310 PEPCID 20 MG TABLET new manufacturer, strength and delivery form
40076031812 Phenergan 12.5 mg suppository new manufacturer, strength and delivery form
40076031912 Phenergan 25 mg suppository new manufacturer, strength and delivery form
40076032012 Phenergan 50 mg suppository new manufacturer, strength and delivery form
64406001201 PLEGRIDY PEN INJ STARTER PACK new drug, strength and delivery form
64406001101 PLEGRIDY 125 MCG/0.5 ML PEN new drug, strength and delivery form
64406001501 PLEGRIDY 125 MCG/0.5 ML SYRING new drug, strength and delivery form
68382053801 POTASSIUM CITRATE ER 15 MEQ TABLET new manufacturer and strength
00378456005 POTASSIUM CITRATE ER 8 MEQ TABLET new manufacturer and strength
00378471022 Prednisolone odt 10 mg tablet new manufacturer, strength and delivery form
00378471522 Prednisolone odt 15 mg tablet new manufacturer, strength and delivery form
00378473022 Prednisolone odt 30 mg tablet new manufacturer, strength and delivery form
10631040701 PROCTOSOL-HC 2.5% CREAM new drug
49663000106 PROCYSBI DR 25 MG CAPSULE new drug and strength
49663000225 PROCYSBI DR 75 MG CAPSULE new drug and strength
40085022012 PROMETHAZINE 50 MG SUPPOSITORY new manufacturer and delivery form
63459010130 PROVIGIL 100 MG TABLET new drug and strength
63459020130 PROVIGIL 200 MG TABLET new drug and strength
62484002001 PURIXAN 20 MG/ML ORAL SUSP new drug
68180055409 QUINAPRIL 40 MG TABLET new manufacturer and strength
59310020212 QVAR 40 MCG ORAL INHALER new drug and strength
59310020412 QVAR 80 MCG ORAL INHALER new drug and strength
63851050102 RABAVERT RABIES VACCINE KIT new drug
00006409402 RECOMBIVAX HB 10 MCG/ML SYR new delivery form and strength
00006409301 RECOMBIVAX HB 5 MCG/0.5 ML SYR new delivery form and strength
65649055102 RELISTOR 12 MG/0.6 ML VIAL new drug
00187517245 RETIN-A 0.01% GEL new strength
00187514445 RETIN-A MICRO 0.04% GEL new strength
00069033621 REVATIO 10 MG/ML ORAL SUSP new delivery form and strength
00003363810 REYATAZ 50 MG POWDER PACKET new delivery form and strength
00054465029 ROXICET 5/325 TABLET new delivery form
68012035001 RUCONEST 2,100 UNIT VIAL new drug
64896066101 RYTARY ER 23.75 MG-95 MG CAP new drug and strength
64896066201 RYTARY ER 36.25 MG-145 MG CAP new drug and strength
64896066301 RYTARY ER 48.75 MG-195 MG CAP new drug and strength
64896066401 RYTARY ER 61.25 MG-245 MG CAP new drug and strength
00456241063 SAPHRIS 10 MG TAB SL BLK CHERY new drug and strength
00456240560 SAPHRIS 5 MG TAB SL BLK CHERRY new drug and strength
65597020130 SAVAYSA 15 MG TABLET new drug and strength
65597020230 SAVAYSA 30 MG TABLET new drug and strength
65597020330 SAVAYSA 60 MG TABLET new drug and strength
16714044101 SHAROBEL 0.35 MG TABLET new drug
59762100201 SIROLIMUS 1 MG TABLET [Rapamune] new manufacturer and strength
59762100301 SIROLIMUS 2 MG TABLET [Rapamune] new manufacturer and strength
00009519901 SOMAVERT 25 MG VIAL new strength
00009520001 SOMAVERT 30 MG VIAL new strength
00299382330 SOOLANTRA 1% CREAM new drug
00597010061 SPIRIVA RESPIMAT INHAL SPRAY new strength
64376013302 STAVUDINE 1 MG/ML SOLUTION new manufacturer, strength and delivery form
00597019261 STRIVERDI RESPIMAT INHAL SPRAY new drug
43376010406 SUMAVEL DOSEPRO 4 MG/0.5 ML new strength
00069083038 SUTENT 37.5 MG CAPSULE new strength
00186037220 SYMBICORT 80; 4.5ug/1; ug/1 1 POUCH in 1 CARTON / 1 CANISTER in 1 POUCH / 120 AEROSOL in 1 CANISTER new strength
00310662702 SYMLINPEN 120 PEN INJECTOR new drug and strength
00310661502 SYMLINPEN 60 PEN INJECTOR new drug and strength
00168041730 Tacrolimus 0.03% ointment new manufacturer, strength and delivery form
00168041630 Tacrolimus 0.1% ointment new manufacturer, strength and delivery form
50102012803 Tarina Fe 1-20 tablet new drug
00462029360 TEMOVATE 0.05% GEL 60GM BOX new delivery form
00603783188 TESTOSTERONE 10 MG GEL PUMP new drug, manufacturer, strength and delivery form
00832112140 TESTOSTERONE 12.5 MG/1.25 GRAM new drug, manufacturer, strength and delivery form
45802011665 TESTOSTERONE 25 MG/2.5 GM PKT new drug, manufacturer, strength and delivery form
00832112005 TESTOSTERONE 50 MG/5 GRAM GEL new drug, manufacturer, strength and delivery form
00832112035 TESTOSTERONE 50 MG/5 GRAM PKT new drug, manufacturer, strength and delivery form
00178850020 TINDAMAX 500 MG TABLET new drug
00832107430 TOPIRAMATE ER 100 MG CAPSULE new manufacturer and delivery form
00832107530 TOPIRAMATE ER 150 MG CAPSULE new manufacturer, strength and delivery form
00832107330 TOPIRAMATE ER 200 MG CAPSULE new manufacturer and delivery form
00832107130 TOPIRAMATE ER 25 MG CAPSULE new manufacturer and delivery form
00832107230 TOPIRAMATE ER 50 MG CAPSULE new manufacturer and delivery form
63459039502 TREANDA 45 MG/0.5 ML VIAL new delivery form and strength
66530025950 TRETINOIN GEL MICRO 0.04% PUMP new manufacturer, strength and delivery form
66530026050 TRETINOIN GEL MICRO 0.1% PUMP new manufacturer, strength and delivery form
66992084010 TREZIX 16-320.5-30 MG CAPSULE new drug
59762371704 TRIAZOLAM 0.125 MG TABLET new manufacturer and strength
49702023113 TRIUMEQ TABLET new drug
00002143380 TRULICITY 0.75 MG/0.5 ML PEN new drug and strength
00002143480 TRULICITY 1.5 MG/0.5 ML PEN new drug and strength
00005010001 TRUMENBA 120 MCG/0.5 ML VACCINE new drug
61958140101 TYBOST 150 MG TABLET new drug
65649065103 UCERIS 2 MG RECTAL FOAM new manufacturer, strength and delivery form
66215001660 VALCHLOR 0.016% GEL new drug
55111076260 VALGANCICLOVIR 450 MG TABLET [Valcyte] new drug
51660014290 VALSARTAN 160 MG TABLET [Diovan] new manufacturer and strength
51660014390 VALSARTAN 320 MG TABLET [Diovan] new manufacturer and strength
51660014030 VALSARTAN 40 MG TABLET [Diovan] new manufacturer and strength
51660014190 VALSARTAN 80 MG TABLET [Diovan] new manufacturer and strength
00006409501 VAQTA 25 UNITS/0.5ML SYRINGE new delivery form
00006409602 VAQTA 50 UNITS/ML SYRINGE new delivery form and strength
00074309328 VIEKIRA PAK new drug
00245087240 VOGELXO 12.5 MG/1.25 GRAM PUMP new delivery form and strength
00245087105 VOGELXO 50 MG/5 GRAM GEL new delivery form
00095020110 VOSOL HC EAR DROPS new drug
59417010110 VYVANSE 10 MG CAPSULE new strength
68180089913 WYMZYA FE CHEWABLE TABLET new drug
50458058451 XARELTO STARTER PACK new delivery form
00310628030 XIGDUO XR 10 MG-1,000 MG TAB new drug and strength
00310627030 XIGDUO XR 10 MG-500 MG TABLET new drug and strength
00310626030 XIGDUO XR 5 MG-1,000 MG TABLET new drug and strength
00310625030 XIGDUO XR 5 MG-500 MG TABLET new drug and strength
42865030602 ZENPEP DR 10,000 UNITS CAPSULE new drug and strength
42865030202 ZENPEP DR 15,000 UNITS CAPSULE new drug and strength
42865030302 ZENPEP DR 20,000 UNITS CAPSULE new drug and strength
42865030502 ZENPEP DR 25,000 UNITS CAPSULE new drug and strength
42865030402 ZENPEP DR 3,000 UNITS CAPSULE new drug and strength
42865030702 ZENPEP DR 40,000 UNITS CAPSULE new drug and strength
42865030002 ZENPEP DR 5,000 UNITS CAPSULE new drug and strength
67919003001 ZERBAXA 1-0.5 GRAM VIAL new drug
17478060930 ZIOPTAN 0.0015% EYE DROPS new drug
40076099155 ZOVIRAX 200 MG CAPSULE new manufacturer, strength and delivery form
40076095396 ZOVIRAX 200 MG/5 ML SUSP new manufacturer, strength and delivery form
57881044401 ZUPLENZ 4 MG SOLUBLE FILM new drug and strength
57881044801 ZUPLENZ 8 MG SOLUBLE FILM new drug and strength
61958170101 ZYDELIG 100 MG TABLET new drug and strength
61958170201 ZYDELIG 150 MG TABLET new drug and strength

Go to the Part 1 blog for the details of the drug in the first 180 new NDCs.

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.